The Pulmonary Center, Department of Medicine, Boston University School of Medicine, Boston, Massachusetts.
Channing Division of Network Medicine, and.
Am J Respir Crit Care Med. 2024 Oct 1;210(7):890-899. doi: 10.1164/rccm.202308-1384OC.
Body mass index (BMI) is associated with chronic obstructive pulmonary disease (COPD) mortality, but the underlying mechanisms are unclear. The effect of genetic variants aggregated into a polygenic score may elucidate the causal mechanisms and predict risk. To examine the associations of genetically predicted BMI with all-cause and cause-specific mortality in COPD. We developed a polygenic score (PGS) for BMI (PGS) and tested for associations of the PGS with all-cause, respiratory, and cardiovascular mortality in participants with COPD from the COPDGene (Genetic Epidemiology of COPD), ECLIPSE (Evaluation of COPD Longitudinally to Identify Predictive Surrogate End-points), and Framingham Heart studies. We calculated the difference between measured BMI and PGS-predicted BMI (BMI) and categorized participants into groups of discordantly low (BMI <20th percentile), concordant (BMI between the 20th and 80th percentiles), and discordantly high (BMI >80th percentile) BMI. We applied Cox models, examined potential nonlinear associations of the PGS and BMI with mortality, and summarized results with meta-analysis. We observed significant nonlinear associations of measured BMI and BMI, but not PGS, with all-cause mortality. In meta-analyses, a one-standard deviation increase in the PGS was associated with an increased hazard for cardiovascular mortality (hazard ratio [HR], 1.29; 95% confidence interval [CI], 1.12-1.49), but not for respiratory or all-cause mortality. Compared with participants with concordant measured and genetically predicted BMI, those with discordantly low BMI had higher risks for all-cause mortality (HR, 1.57; 95% CI, 1.41-1.74) and respiratory death (HR, 2.01; 95% CI, 1.61-2.51). In people with COPD, a higher genetically predicted BMI is associated with higher cardiovascular mortality but not respiratory mortality. Individuals with a discordantly low BMI have higher all-cause and respiratory mortality rates than those with a concordant BMI.
体重指数 (BMI) 与慢性阻塞性肺疾病 (COPD) 死亡率相关,但潜在机制尚不清楚。聚集在多基因评分中的遗传变异的影响可能阐明因果机制并预测风险。 研究遗传预测 BMI 与 COPD 患者全因和特定原因死亡率的相关性。 我们开发了一种 BMI 的多基因评分 (PGS) (PGS),并在 COPDGene(COPD 的遗传流行病学)、ECLIPSE(评估 COPD 纵向以确定预测替代终点)和弗雷明汉心脏研究中的 COPD 参与者中测试了 PGS 与全因、呼吸和心血管死亡率的相关性。我们计算了测量 BMI 与 PGS 预测 BMI(BMI)之间的差异,并将参与者分为 BMI 低于第 20 百分位数的低不相符组(BMI <20th percentile)、BMI 处于第 20 至 80 百分位之间的相符组(BMI between the 20th and 80th percentiles)和 BMI 高于第 80 百分位的高不相符组(BMI >80th percentile)。我们应用 Cox 模型,检查 PGS 和 BMI 与死亡率的潜在非线性关联,并通过荟萃分析总结结果。 我们观察到测量的 BMI 和 BMI 与全因死亡率呈显著非线性关联,但 PGS 则没有。在荟萃分析中,PGS 增加一个标准差与心血管死亡率的风险增加相关(危险比 [HR],1.29;95%置信区间 [CI],1.12-1.49),但与呼吸或全因死亡率无关。与具有一致测量和遗传预测 BMI 的参与者相比,BMI 不相符的参与者全因死亡率(HR,1.57;95%CI,1.41-1.74)和呼吸死亡(HR,2.01;95%CI,1.61-2.51)风险更高。 在 COPD 患者中,较高的遗传预测 BMI 与心血管死亡率升高相关,但与呼吸死亡率无关。BMI 不相符的个体比 BMI 相符的个体具有更高的全因和呼吸死亡率。